Cardlytics Files DEF 14A for 2024 Executive Disclosures
Ticker: CDLX · Form: DEF 14A · Filed: Apr 3, 2025 · CIK: 1666071
| Field | Detail |
|---|---|
| Company | Cardlytics, Inc. (CDLX) |
| Form Type | DEF 14A |
| Filed Date | Apr 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
Related Tickers: CDLX
TL;DR
Cardlytics DEF 14A out - exec pay details for 2024 coming.
AI Summary
Cardlytics, Inc. filed its DEF 14A on April 3, 2025, detailing executive compensation and corporate governance matters. The filing covers the fiscal year ending December 31, 2024, and includes information on board members such as Amit Gupta, Karim Temsamani, and Lynne Laube. Specific financial figures for compensation are not detailed in this excerpt but are central to the purpose of a DEF 14A filing.
Why It Matters
This filing provides shareholders with crucial information regarding executive compensation and board oversight, enabling informed voting decisions on corporate governance matters.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) that primarily discloses executive compensation and governance information, not typically indicative of immediate operational or financial risk.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for executive compensation and governance)
- 20250403 — Filing Date (Date the DEF 14A was submitted to the SEC)
Key Players & Entities
- Cardlytics, Inc. (company) — Filer
- Amit Gupta (person) — Board Member
- Karim Temsamani (person) — Board Member
- Lynne Laube (person) — Board Member
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit shareholder votes on important corporate matters, most notably executive compensation, director elections, and other governance issues.
Which fiscal year does this DEF 14A filing primarily cover?
This DEF 14A filing by Cardlytics, Inc. covers the fiscal year ending December 31, 2024.
Who are some of the individuals mentioned in relation to Cardlytics' board or governance?
The filing mentions Amit Gupta, Karim Temsamani, and Lynne Laube in contexts related to board membership and fiscal years.
What is the SEC file number for Cardlytics, Inc.?
The SEC file number for Cardlytics, Inc. is 001-38386.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 3, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 3, 2025 by Amit Gupta regarding Cardlytics, Inc. (CDLX).